These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 22338582

  • 1. Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia.
    Gibbons AS, Scarr E, Boer S, Money T, Jeon WJ, Felder C, Dean B.
    Int J Neuropsychopharmacol; 2013 Feb; 16(1):37-46. PubMed ID: 22338582
    [Abstract] [Full Text] [Related]

  • 2. Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1.
    Dean B, Soulby A, Evin GM, Scarr E.
    Schizophr Res; 2008 Dec; 106(2-3):229-36. PubMed ID: 18790604
    [Abstract] [Full Text] [Related]

  • 3. Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia.
    Deng C, Huang XF.
    J Neurosci Res; 2005 Sep 15; 81(6):883-90. PubMed ID: 16041805
    [Abstract] [Full Text] [Related]

  • 4. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder.
    Zavitsanou K, Katsifis A, Mattner F, Huang XF.
    Neuropsychopharmacology; 2004 Mar 15; 29(3):619-25. PubMed ID: 14694353
    [Abstract] [Full Text] [Related]

  • 5. M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.
    Zavitsanou K, Katsifis A, Yu Y, Huang XF.
    Brain Res Bull; 2005 May 15; 65(5):397-403. PubMed ID: 15833594
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. No change in cortical muscarinic M2, M3 receptors or [35S]GTPgammaS binding in schizophrenia.
    Scarr E, Keriakous D, Crossland N, Dean B.
    Life Sci; 2006 Feb 09; 78(11):1231-7. PubMed ID: 16214178
    [Abstract] [Full Text] [Related]

  • 8. Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia.
    Scarr E, Cowie TF, Kanellakis S, Sundram S, Pantelis C, Dean B.
    Mol Psychiatry; 2009 Nov 09; 14(11):1017-23. PubMed ID: 18317461
    [Abstract] [Full Text] [Related]

  • 9. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia.
    Newell KA, Zavitsanou K, Jew SK, Huang XF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):225-33. PubMed ID: 16901598
    [Abstract] [Full Text] [Related]

  • 10. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.
    Crook JM, Tomaskovic-Crook E, Copolov DL, Dean B.
    Am J Psychiatry; 2001 Jun 30; 158(6):918-25. PubMed ID: 11384900
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Opposing short- and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment.
    Newell KA, Zavitsanou K, Huang XF.
    J Neurosci Res; 2007 May 01; 85(6):1358-63. PubMed ID: 17342780
    [Abstract] [Full Text] [Related]

  • 15. Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease.
    Scarr E, McLean C, Dean B.
    J Neural Transm (Vienna); 2017 Mar 01; 124(3):273-284. PubMed ID: 27688247
    [Abstract] [Full Text] [Related]

  • 16. Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia.
    Dean B, McLeod M, Keriakous D, McKenzie J, Scarr E.
    Mol Psychiatry; 2002 Mar 01; 7(10):1083-91. PubMed ID: 12476323
    [Abstract] [Full Text] [Related]

  • 17. Development of a Selective and High Affinity Radioligand, [3H]VU6013720, for the M4 Muscarinic Receptor.
    Qi A, Kling HE, Billard N, Rodriguez AL, Peng L, Dickerson JW, Engers JL, Bender AM, Moehle MS, Lindsley CW, Rook JM, Niswender CM.
    Mol Pharmacol; 2023 Nov 01; 104(5):195-202. PubMed ID: 37595966
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.